
Andreas Obst
FC Bayern Munich
OUT
Injury Illness
Est. Return 1/22/2026
Inactive for Round 23
Obst will not play Tuesday against Partizan due to an illness, according to Bayern's official X account.
ANALYSIS
It's unclear exactly what type of ailment Obst is dealing with, but it will prevent him from seeing action in Round 23. It remains to be seen who will replace him in Bayern's starting lineup.
It's unclear exactly what type of ailment Obst is dealing with, but it will prevent him from seeing action in Round 23. It remains to be seen who will replace him in Bayern's starting lineup.
EuroLeague Per Game Stats
Per Game
Total
Per 36
EuroLeague Per Game Stats
Loading Per Game Stats...
Game Log
2025
2024
2023
2022
2021
Game Log
Loading Game Log...
Advanced Stats
Loading Advanced Stats...
FC Bayern Munich Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Catches fire in win
Obst registered a career-high 37 points, three rebounds, two assists and seven three-pointers in Wednesday's victory over Baskonia.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Puts up 21 points
Obst had 21 points, three rebounds, three assists and five three-pointers in Friday's loss to Dubai.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Sees action Sunday
Obst recorded 13 points, two assists and two three-pointers over 24 minutes off the bench in Sunday's domestic contest.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Out for Round 11
Obst will not play Friday against Efes, according to Bayern's official X account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Goes for 21 points
Obst delivered 21 points, three rebounds and four three-pointers in Thursday's win over Virtus Bologna.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.